We are delighted to announce that Pauli Wong, Partner at Eagle IP, has been invited to speak at the Entrepreneurship Series 2026, organized by the Hong Kong Life Sciences Society (HKLSS).

Pauli will lead an essential session titled "Protecting Innovation through IP and Legal Strategy," tailored specifically for the next generation of life sciences entrepreneurs, researchers, and biotech professionals. In an industry where intellectual property is often the most valuable asset a company owns, this seminar aims to equip participants with the strategic mindset needed to safeguard their scientific breakthroughs.

At Eagle IP, we are committed to empowering the local life sciences ecosystem. We are proud to partner with HKLSS in their mission to nurture talent and bridge the gap between academic excellence and commercial success in the life sciences sector.

我们的过去活动

Recommended Insights

Twice the Trouble: Unraveling a Single Case of Dual Patent and Trademark Infringement

2024年1月9日
Can a rights holder sue the same infringer separately based on one single infringing act that infringes both trademark and patent rights? An interesting case this year from China’s Supreme People’s Court that addresses this specific issue ((2023)最高法知民终235号). Beijing Run De Hong Tu Technology Development Co., Ltd. (“Run De Hong Tu”) sued an individual named […]

China Top 10 Cases of 2020 – CNIPA Upholds Second Medical Use Patent from University of Bordeaux

2021年5月24日
The development of China’s approach to patents, especially those in the pharmaceutical and biotech space, has been fascinating to watch. Those of us who have practiced in the area for a long time have been frustrated by the Chinese patent office’s overly strict rules regarding patentability (e.g., high data support standard and refusal to consider […]

Foreigners Beware: China Proposes Requiring IP Made Using Exported Chinese Genetic Resources to be Co-Owned by Chinese Collaborators

2023年3月22日
Proposed Examination Guidelines for the New Chinese Patent Law – Topic 2: Genetic Resource Restriction How Will the Tightened Genetic Resource Restrictions Affect Your IP In 2019-2021, China’s Ministry of Science and Technology (“MOST”, or the Science Ministry) established several laws and regulations with respect to biosafety1 and human genetic resources management2 (collectively referred as […]

Markush claims in China - what can be arbitrarily deleted during invalidation?

2018年12月4日
Since 2010, the China Patent Re-examination Board (PRB) has published the top 10 patent invalidation cases of the year in April of each year. The selection criteria are high social concern, significant impact on the related industry, or involve difficult legal issues and important examination criteria. Below is one of the top 10 cases that […]
Top crossarrow-right